Ark Biopharmaceutical Receives China Marketing Authorization for Aizhida for the Treatment of ADHD Written by PR Newswire Enable JavaScript and cookies to continueFigure_1_Each_Aizhida_capsule_70__SDX_30__d_MPH.jpg?p=medium600#Read more http://www.prnasia.com/story/archive/4859191_AE59191_0